Journal of Pharmacy And Bioallied Sciences
Journal of Pharmacy And Bioallied Sciences Login  | Users Online: 1201  Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size 
    Home | About us | Editorial board | Search | Ahead of print | Current Issue | Past Issues | Instructions | Online submission

    Article Cited by others


Food and drug administration's critical path initiative and innovations in drug development paradigm: Challenges, progress, and controversies

Mahajan Rajiv, Gupta Kapil

Year : 2010| Volume: 2| Issue : 4 | Page no: 307-313

   This article has been cited by
1 Visualizing Extracellular Vesicles and Their Function in 3D Tumor Microenvironment Models
Evran E. Ural, Victoria Toomajian, Ehsanul Hoque Apu, Mladen Veletic, Ilangko Balasingham, Nureddin Ashammakhi, Masamitsu Kanada, Christopher H. Contag
International Journal of Molecular Sciences. 2021; 22(9): 4784
[Pubmed]  [Google Scholar] [DOI]
2 Entering the era of computationally driven drug development
Neha Maharao, Victor Antontsev, Matthew Wright, Jyotika Varshney
Drug Metabolism Reviews. 2020; 52(2): 283
[Pubmed]  [Google Scholar] [DOI]
3 The role of regulators in mitigating uncertainty within the Valley of Death
Jaime Bonnin Roca, Eoin O'Sullivan
Technovation. 2020; : 102157
[Pubmed]  [Google Scholar] [DOI]
4 Advanced Research and Data Methods in Women's Health
Christian R. Macedonia,Clark T. Johnson,Indika Rajapakse
Obstetrics & Gynecology. 2017; 129(2): 249
[Pubmed]  [Google Scholar] [DOI]
5 Attitudes and opinions regarding confirmatory adaptive clinical trials: a mixed methods analysis from the Adaptive Designs Accelerating Promising Trials into Treatments (ADAPT-IT) project
William J. Meurer,Laurie Legocki,Samkeliso Mawocha,Shirley M. Frederiksen,Timothy C. Guetterman,William Barsan,Roger Lewis,Donald Berry,Michael Fetters
Trials. 2016; 17(1)
[Pubmed]  [Google Scholar] [DOI]
6 Multiparametric magnetic resonance imaging predicts clinical outcomes in patients with chronic liver disease
Michael Pavlides,Rajarshi Banerjee,Joanne Sellwood,Catherine J. Kelly,Matthew D. Robson,Jonathan C. Booth,Jane Collier,Stefan Neubauer,Eleanor Barnes
Journal of Hepatology. 2016; 64(2): 308
[Pubmed]  [Google Scholar] [DOI]
7 Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014
Natalie J. Torok,Jonathan A. Dranoff,Detlef Schuppan,Scott L. Friedman
Hepatology. 2015; 62(2): 627
[Pubmed]  [Google Scholar] [DOI]
8 An implantable microdevice to perform high-throughput in vivo drug sensitivity testing in tumors
O. Jonas,H. M. Landry,J. E. Fuller,J. T. Santini,J. Baselga,R. I. Tepper,M. J. Cima,R. Langer
Science Translational Medicine. 2015; 7(284): 284ra57
[Pubmed]  [Google Scholar] [DOI]
9 The Synthesis of Highly Active Iridium(I) Complexes and their Application in Catalytic Hydrogen Isotope Exchange
Jack A. Brown,Alison R. Cochrane,Stephanie Irvine,William J. Kerr,Bhaskar Mondal,John A. Parkinson,Laura C. Paterson,Marc Reid,Tell Tuttle,Shalini Andersson,Göran N. Nilsson
Advanced Synthesis & Catalysis. 2014; : n/a
[Pubmed]  [Google Scholar] [DOI]
10 Emerging approaches in predictive toxicology
Luoping Zhang,Cliona M. McHale,Nigel Greene,Ronald D. Snyder,Ivan N. Rich,Marilyn J. Aardema,Shambhu Roy,Stefan Pfuhler,Sundaresan Venkatactahalam
Environmental and Molecular Mutagenesis. 2014; 55(9): 679
[Pubmed]  [Google Scholar] [DOI]
11 Practically convenient and industrially-aligned methods for iridium-catalysed hydrogen isotope exchange processes
A. R. Cochrane,C. Idziak,W. J. Kerr,B. Mondal,L. C. Paterson,T. Tuttle,S. Andersson,G. N. Nilsson
Organic & Biomolecular Chemistry. 2014; 12(22): 3598
[Pubmed]  [Google Scholar] [DOI]
12 Mechanistic systems modeling to guide drug discovery and development
Brian J. Schmidt,Jason A. Papin,Cynthia J. Musante
Drug Discovery Today. 2013; 18(3-4): 116
[Pubmed]  [Google Scholar] [DOI]
13 Pharm-Econogenomics: A New Appraisal
Paddy M Barrett, Eric J Topol
Clinical Chemistry. 2013; 59(4): 592
[Pubmed]  [Google Scholar] [DOI]
14 Preclinicalin vivoADME studies in drug development: a critical review
Mario Pellegatti
Expert Opinion on Drug Metabolism & Toxicology. 2012; 8(2): 161
[Pubmed]  [Google Scholar] [DOI]
15 Data Mining and Meta-Analysis on DNA Microarray Data
Triantafyllos Paparountas,Maria Nefeli Nikolaidou-Katsaridou,Gabriella Rustici,Vasilis Aidinis
International Journal of Systems Biology and Biomedical Technologies. 2012; 1(3): 1
[Pubmed]  [Google Scholar] [DOI]
16 Pharmacodynamic end points in early-phase oncology trials
Giovanna Speranza,James H Doroshow,Shivaani Kummar
Clinical Investigation. 2012; 2(7): 679
[Pubmed]  [Google Scholar] [DOI]
17 Bayesian adaptive clinical trials: a dream for statisticians only?
Sylvie Chevret
Statistics in Medicine. 2012; 31(11-12): 1002
[Pubmed]  [Google Scholar] [DOI]
18 Medication errors - new approaches to prevention
Alan F. Merry,Brian J. Anderson
Pediatric Anesthesia. 2011; 21(7): 743
[Pubmed]  [Google Scholar] [DOI]


Read this article